Income Statement Lotte Chemical Corporation

Equities

A011170

KR7011170008

Commodity Chemicals

End-of-day quote Korea S.E. Other stock markets 20/05/2026			5-day change	1st Jan Change
79,000.00 ^KRW	-3.66%		-11.34%	+12.38%

05-11	Lotte Chemical Corporation, Q1 2026 Earnings Call, May 11, 2026
05-11	Lotte Chemical Corp Q1 preliminary operating profit 73.5 billion won versus operating loss of 126.6 billion won a year ago	RE

3d1e7253cae2f96.7s7KB-uDfMwl7uMHTfnuyebCBYt3WRKpf8S7dDED5mQ.l6OoM5nhGIpJhYZ-fs2FvNG1Zs4ELyXtPLTNEF40sC6G_p5YvfsNuWyUlA

Published financial data: LOTTE CHEMICAL CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	18,120B	22,276B	19,946B	20,430B	18,483B
Other Revenues, Total	-10	-10	-10	-	-10
Total Revenues	18,120B	22,276B	19,946B	20,430B	18,483B
Cost of Goods Sold, Total	15,671B	22,008B	19,182B	20,117B	18,238B
Gross Profit	2,450B	268B	765B	313B	245B
Selling General & Admin Expenses, Total	776B	865B	930B	1T	989B
Provision for Bad Debts	-337M	2.15B	14.46B	-9.92B	2.24B
R&D Expenses	92.45B	102B	120B	148B	135B
Depreciation & Amortization - (IS)	26.18B	31.27B	38.08B	38.71B	38.52B
Amortization of Goodwill and Intangible Assets - (IS)	10.06B	20.13B	5.81B	6.6B	9.79B
Other Operating Expenses	9.62B	10.17B	15.59B	13.16B	12.24B
Other Operating Expenses, Total	914B	1,031B	1,124B	1,196B	1,187B
Operating Income	1,536B	-763B	-359B	-883B	-943B
Interest Expense, Total	-85.17B	-150B	-379B	-421B	-408B
Interest And Investment Income	31.58B	75.2B	206B	180B	125B
Net Interest Expenses	-53.59B	-74.69B	-173B	-241B	-284B
Income (Loss) On Equity Invest.	381B	-19.26B	54.74B	-121B	-212B
Currency Exchange Gains (Loss)	-22.07B	-72.26B	-14.82B	21.53B	-71.02B
Other Non Operating Income (Expenses)	75.82B	649B	20.42B	109B	-47.27B
EBT, Excl. Unusual Items	1,917B	-280B	-472B	-1,115B	-1,557B
Impairment of Goodwill	-	-334B	-	-	-
Gain (Loss) On Sale Of Investments	17.19B	-76.82B	-57.22B	-98.73B	-191B
Gain (Loss) On Sale Of Assets	-15.22B	5.28B	19.21B	-5.82B	31.63M
Asset Writedown	-16.22B	-113B	-116B	-1,042B	-966B
Insurance Settlements	-	406B	174B	2.87B	4.62B
EBT, Incl. Unusual Items	1,902B	-393B	-452B	-2,258B	-2,710B
Income Tax Expense	477B	-420B	-413B	-433B	-227B
Earnings From Continuing Operations	1,426B	27.82B	-39.24B	-1,826B	-2,483B
Earnings Of Discontinued Operations	-	-	-	-	7.3B
Net Income to Company	1,426B	27.82B	-39.24B	-1,826B	-2,476B
Minority Interest	-79.95B	33.77B	-10.8B	115B	439B
Net Income - (IS)	1,346B	61.59B	-50.04B	-1,711B	-2,037B
Net Income to Common Incl Extra Items	1,346B	61.59B	-50.04B	-1,711B	-2,037B
Net Income to Common Excl. Extra Items	1,346B	61.59B	-50.04B	-1,711B	-2,044B
Per Share Items
Net EPS - Basic	39.26K	1.8K	-1.2K	-40.56K	-48.31K
Basic EPS - Continuing Operations	39.26K	1.8K	-1.2K	-40.56K	-48.48K
Basic Weighted Average Shares Outstanding	34.28M	34.18M	41.74M	42.17M	42.17M
Net EPS - Diluted	39.26K	1.8K	-1.2K	-40.56K	-48.31K
Diluted EPS - Continuing Operations	39.26K	1.8K	-1.2K	-40.56K	-48.48K
Diluted Weighted Average Shares Outstanding	34.28M	34.18M	41.74M	42.17M	42.17M
Normalized Basic EPS	32.61K	-4.13K	-7.33K	-13.79K	-12.67K
Normalized Diluted EPS	32.61K	-4.13K	-7.33K	-13.79K	-12.67K
Dividend Per Share	8.3K	3.5K	3.5K	2K	-
Payout Ratio	11.84	568.51	-379.11	-13.18	-4.08
Supplemental Items
EBITDA	2,368B	185B	813B	407B	290B
EBITA	1,624B	-663B	-174B	-672B	-776B
EBIT	1,536B	-763B	-359B	-883B	-943B
EBITDAR	2,381B	203B	829B	425B	308B
Effective Tax Rate - (Ratio)	25.06	107.09	91.32	19.16	8.36
Normalized Net Income	1,118B	-141B	-306B	-582B	-534B
Interest Capitalized	-	10.05B	-	-	-
Supplemental Operating Expense Items
Advertising Expense	42.24B	17.02B	21.79B	48.09B	46.59B
Marketing Expenses	12.31B	10.96B	10.09B	10.83B	10.8B
Selling and Marketing Expenses	458B	511B	525B	564B	561B
General and Administrative Expenses	7.98B	10.96B	13.01B	12.55B	10.61B
Research And Development Expense From Footnotes	92.45B	102B	120B	148B	135B
Net Rental Expense, Total	12.6B	17.95B	15.69B	17.73B	18.2B
Imputed Operating Lease Interest Expense	2.44B	-	5.82B	5.78B	5.79B
Imputed Operating Lease Depreciation	10.16B	-	9.87B	11.95B	12.41B
Maintenance & Repair Expenses, Total	14.18B	15.34B	16.61B	16.92B	17.45B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1,603B	2,810B	2,702B	2,112B	1,870B
Short Term Investments	1,704B	353B	1,114B	1,334B	838B
Trading Asset Securities, Total	1,180B	566B	112B	39.81B	17.55B
Total Cash And Short Term Investments	4,487B	3,729B	3,927B	3,486B	2,726B
Accounts Receivable, Total	1,903B	2,088B	2,268B	2,090B	1,785B
Other Receivables	35.19B	198B	75.31B	107B	103B
Notes Receivable	378M	500B	301B	26.57B	60.36B
Total Receivables	1,939B	2,786B	2,644B	2,223B	1,948B
Inventory	2,793B	2,549B	2,802B	2,818B	2,910B
Prepaid Expenses	142B	269B	271B	323B	306B
Other Current Assets, Total	69.64B	133B	170B	129B	105B
Total Current Assets	9,431B	9,466B	9,814B	8,979B	7,994B
Gross Property Plant And Equipment	18,410B	23,621B	28,276B	31,522B	30,301B
Accumulated Depreciation	-10,583B	-12,510B	-13,564B	-14,973B	-15,331B
Net Property Plant And Equipment	7,827B	11,111B	14,711B	16,549B	14,970B
Long-term Investments	4,028B	4,332B	4,460B	4,402B	3,992B
Goodwill	647B	339B	2,001B	1,640B	1,143B
Other Intangibles, Total	709B	878B	1,731B	1,674B	1,502B
Accounts Receivable Long-Term	2.38B	6.06B	8.46B	8.18B	15.92B
Loans Receivable Long-Term	1.59B	863M	12.19B	201B	200B
Deferred Tax Assets Long-Term	25.03B	58.09B	403B	723B	813B
Other Long-Term Assets, Total	200B	593B	335B	374B	486B
Total Assets	22,870B	26,785B	33,476B	34,552B	31,117B
Liabilities
Accounts Payable, Total	1,668B	1,528B	1,354B	1,276B	1,366B
Accrued Expenses, Total	64.35B	115B	101B	200B	86.9B
Short-term Borrowings	1,020B	3,044B	3,494B	2,788B	3,315B
Current Portion of Long-Term Debt	735B	837B	626B	2,487B	1,382B
Current Portion of Leases	22.38B	37.36B	49.85B	61.85B	54.38B
Current Income Taxes Payable	228B	119B	66.06B	36.4B	16.4B
Unearned Revenue Current, Total	243B	17.62B	10.38B	1.02B	1.9B
Other Current Liabilities	599B	686B	822B	1,653B	1,452B
Total Current Liabilities	4,579B	6,384B	6,524B	8,502B	7,674B
Long-Term Debt	1,793B	2,288B	5,708B	5,131B	4,957B
Long-Term Leases	95.47B	119B	137B	197B	161B
Unearned Revenue Non Current	12.41B	11.36B	10.22B	9.2B	156B
Pension & Other Post Retirement Benefits	-	7.68B	38.05B	38.26B	25.91B
Deferred Tax Liability Non Current	757B	448B	543B	411B	337B
Other Non Current Liabilities	181B	263B	284B	276B	178B
Total Liabilities	7,419B	9,520B	13,244B	14,564B	13,489B
Common Stock, Total	171B	171B	214B	214B	214B
Additional Paid In Capital	876B	826B	1,943B	1,730B	2,086B
Retained Earnings	13,308B	13,139B	12,965B	11,062B	9,044B
Comprehensive Income and Other	55.58B	310B	422B	1,346B	1,241B
Total Common Equity	14,410B	14,445B	15,543B	14,352B	12,585B
Minority Interest	1,041B	2,819B	4,689B	5,636B	5,044B
Total Equity	15,451B	17,264B	20,233B	19,988B	17,628B
Total Liabilities And Equity	22,870B	26,785B	33,476B	34,552B	31,117B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	34.28M	33.99M	42.17M	42.17M	42.17M
ECS Total Common Shares Outstanding	34.28M	33.99M	42.17M	42.17M	42.17M
Book Value / Share	420K	425K	369K	340K	298K
Tangible Book Value	13,055B	13,228B	11,811B	11,038B	9,940B
Tangible Book Value Per Share	381K	389K	280K	262K	236K
Total Debt	3,666B	6,325B	10,014B	10,664B	9,869B
Net Debt	-821B	2,595B	6,087B	7,179B	7,143B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-128B	-	-6.94B	-
Debt Equivalent Oper. Leases	101B	144B	126B	142B	146B
Minority Interest, Total (Incl. Fin. Div)	1,041B	2,819B	4,689B	5,636B	5,044B
Equity Method Investments, Total	3,706B	3,808B	3,834B	3,854B	3,779B
Inventories - Raw Materials, Total	1,028B	1,055B	976B	1,027B	1,182B
Inventories - Work In Process, Total	416B	403B	519B	614B	620B
Inventories - Finished Goods, Total	1,399B	1,315B	1,408B	1,294B	1,239B
Inventories - Others	-330	420	310	1.32K	-190
Land - (BS)	895B	1,431B	1,504B	1,507B	1,471B
Buildings, Total	3,122B	3,724B	4,050B	4,507B	4,954B
Machinery, Total	12,551B	14,710B	15,683B	17,196B	21,064B
Full Time Employees	-	4.57K	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	2.41B	4.96B	4.96B	6.12B	6.66B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1,346B	61.59B	-50.04B	-1,711B	-2,037B
Depreciation & Amortization - CF	744B	848B	987B	1,079B	1,066B
Amortization of Goodwill and Intangible Assets - (CF)	88.57B	99.5B	185B	211B	167B
Depreciation & Amortization, Total	833B	948B	1,173B	1,291B	1,233B
Minority Interest in Earnings - (CF)	-	-4.26B	-1.44B	-256M	163M
(Gain) Loss From Sale Of Asset	15.22B	-5.28B	-56.08B	5.82B	108B
(Gain) Loss on Sale of Investments - (CF)	-17.41B	76.82B	57.22B	98.73B	191B
Asset Writedown & Restructuring Costs	16.22B	447B	116B	1,042B	966B
(Income) Loss On Equity Investments - (CF)	-450B	-26.94B	-19.25B	121B	105B
Provision and Write-off of Bad Debts	-337M	1.83B	2.89B	-9.92B	2.24B
Other Operating Activities, Total	546B	-1,261B	-543B	-324B	-152B
Change In Accounts Receivable	-471B	132B	-91.76B	304B	194B
Change In Inventories	-1,200B	383B	216B	105B	-230B
Change In Accounts Payable	748B	-269B	-203B	1,495B	26.72B
Change in Other Net Operating Assets	120B	-652B	189B	-875B	81.92B
Cash from Operations	1,486B	-167B	790B	1,542B	489B
Capital Expenditure	-773B	-2,593B	-3,640B	-2,238B	-1,621B
Sale of Property, Plant, and Equipment	4.4B	12B	61.07B	13.98B	41.77B
Cash Acquisitions	-	342B	-2,242B	-	-
Divestitures	3B	-	-	-	47.32B
Sale (Purchase) of Real Estate properties	-	-	30.6B	-	-
Sale (Purchase) of Intangible assets	-2.01B	-6.12B	-5.76B	-16.87B	-11.28B
Investment in Marketable and Equity Securities, Total	-808B	1,942B	376B	-117B	708B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-500B	-	-	-
Other Investing Activities, Total	117B	115B	346B	410B	255B
Cash from Investing	-1,458B	-688B	-5,075B	-1,948B	-581B
Short Term Debt Issued, Total	2,266B	4,439B	-	-	-
Long-Term Debt Issued, Total	457B	1,319B	8,272B	5,091B	6,979B
Total Debt Issued	2,722B	5,758B	8,272B	5,091B	6,979B
Short Term Debt Repaid, Total	-1,891B	-2,348B	-	-52.22B	-
Long-Term Debt Repaid, Total	-678B	-823B	-4,810B	-5,015B	-7,266B
Total Debt Repaid	-2,569B	-3,171B	-4,810B	-5,067B	-7,266B
Issuance of Common Stock	-	-	1,216B	-	-
Repurchase of Common Stock	-	-49.73B	-49.97B	-	-
Common & Preferred Stock Dividends Paid	-159B	-350B	-190B	-225B	-83.2B
Common & Preferred Stock Dividends Paid	-159B	-350B	-190B	-225B	-83.2B
Other Financing Activities, Total	-1.56B	-55.01B	-242B	13.78B	221B
Cash from Financing	-7.11B	2,132B	4,196B	-188B	-149B
Foreign Exchange Rate Adjustments	59.83B	-69.52B	-18.85B	3.59B	-529M
Miscellaneous Cash Flow Adjustments	-	450	-	-	-
Net Change in Cash	80.57B	1,207B	-108B	-590B	-241B
Supplemental Items
Cash Interest Paid	52.37B	112B	333B	449B	418B
Cash Income Tax Paid (Refund)	137B	422B	191B	52.66B	-13.45B
Levered Free Cash Flow	339B	-3,350B	-3,198B	-574B	-1,263B
Unlevered Free Cash Flow	393B	-3,256B	-2,961B	-311B	-1,007B
Change In Net Working Capital	625B	1,129B	263B	-1,206B	18.48B
Net Debt Issued / Repaid	154B	2,587B	3,462B	24.1B	-287B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.54	-1.92	-0.75	-1.62	-1.79
Return on Total Capital	5.3	-2.23	-0.83	-1.81	-2.03
Return On Equity %	9.78	0.17	-0.21	-9.08	-13.2
Return on Common Equity	9.87	0.43	-0.33	-11.44	-15.18
Margin Analysis
Gross Profit Margin %	13.52	1.2	3.83	1.53	1.32
SG&A Margin	4.28	3.88	4.66	4.89	5.35
EBITDA Margin %	13.07	0.83	4.08	1.99	1.57
EBITA Margin %	8.96	-2.98	-0.87	-3.29	-4.2
EBIT Margin %	8.47	-3.42	-1.8	-4.32	-5.1
Income From Continuing Operations Margin %	7.87	0.12	-0.2	-8.94	-13.44
Net Income Margin %	7.43	0.28	-0.25	-8.37	-11.02
Net Avail. For Common Margin %	7.43	0.28	-0.25	-8.37	-11.06
Normalized Net Income Margin	6.17	-0.63	-1.53	-2.85	-2.89
Levered Free Cash Flow Margin	1.87	-15.04	-16.03	-2.81	-6.83
Unlevered Free Cash Flow Margin	2.17	-14.62	-14.84	-1.52	-5.45
Asset Turnover
Asset Turnover	0.86	0.9	0.66	0.6	0.56
Fixed Assets Turnover	2.37	2.35	1.54	1.31	1.17
Receivables Turnover (Average Receivables)	11	11.16	9.16	9.38	9.54
Inventory Turnover (Average Inventory)	7.2	8.24	7.17	7.16	6.37
Short Term Liquidity
Current Ratio	2.06	1.48	1.5	1.06	1.04
Quick Ratio	1.4	0.94	0.96	0.67	0.6
Operating Cash Flow to Current Liabilities	0.32	-0.03	0.12	0.18	0.06
Days Sales Outstanding (Average Receivables)	33.17	32.7	39.85	39.03	38.25
Days Outstanding Inventory (Average Inventory)	50.66	44.3	50.91	51.12	57.32
Average Days Payable Outstanding	27.35	26.8	27.07	23.91	26.3
Cash Conversion Cycle (Average Days)	56.48	50.19	63.68	66.25	69.27
Long Term Solvency
Total Debt/Equity	23.72	36.63	49.5	53.35	55.98
Total Debt / Total Capital	19.18	26.81	33.11	34.79	35.89
LT Debt/Equity	12.22	13.94	28.89	26.66	29.03
Long-Term Debt / Total Capital	9.88	10.2	19.32	17.38	18.61
Total Liabilities / Total Assets	32.44	35.54	39.56	42.15	43.35
EBIT / Interest Expense	18.03	-5.09	-0.95	-2.1	-2.31
EBITDA / Interest Expense	27.81	1.23	2.15	0.97	0.71
(EBITDA - Capex) / Interest Expense	18.73	-16.06	-7.46	-4.35	-3.26
Total Debt / EBITDA	1.55	34.19	12.31	26.18	34.02
Net Debt / EBITDA	-0.35	14.03	7.48	17.62	24.63
Total Debt / (EBITDA - Capex)	2.3	-2.63	-3.54	-5.82	-7.41
Net Debt / (EBITDA - Capex)	-0.51	-1.08	-2.15	-3.92	-5.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	48.25	22.93	-10.46	2.43	-7.1
Gross Profit, 1 Yr. Growth %	115.23	-89.06	185.38	-59.08	-15.11
EBITDA, 1 Yr. Growth %	99.36	-92.19	339.64	-49.92	-25.02
EBITA, 1 Yr. Growth %	263.42	-140.85	-73.79	286.47	12.01
EBIT, 1 Yr. Growth %	330.06	-149.68	-52.91	145.88	4.3
Earnings From Cont. Operations, 1 Yr. Growth %	713.01	-98.03	-241.06	4.55K	35.08
Net Income, 1 Yr. Growth %	749.16	-95.38	-181.25	3.32K	19.1
Normalized Net Income, 1 Yr. Growth %	596.17	-112.74	106.92	90.18	-10.19
Diluted EPS Before Extra, 1 Yr. Growth %	749.16	-95.37	-166.53	3.28K	18.63
Accounts Receivable, 1 Yr. Growth %	36.92	9.68	8.62	-7.84	-14.6
Inventory, 1 Yr. Growth %	79.37	-8.75	9.92	0.6	3.25
Net Property, Plant and Equip., 1 Yr. Growth %	4.79	41.97	32.4	12.49	-9.54
Total Assets, 1 Yr. Growth %	17.97	17.19	24.98	3.21	-9.94
Tangible Book Value, 1 Yr. Growth %	14.78	1.42	-10.71	-6.54	-9.95
Common Equity, 1 Yr. Growth %	12.17	0.33	7.6	-7.66	-12.31
Cash From Operations, 1 Yr. Growth %	13.38	-111.27	-571.46	95.36	-68.3
Capital Expenditures, 1 Yr. Growth %	-3.62	235.25	40.4	-38.51	-27.56
Levered Free Cash Flow, 1 Yr. Growth %	-29.99	-1.09K	-4.55	-82.06	115.61
Unlevered Free Cash Flow, 1 Yr. Growth %	-28.88	-929.28	-9.08	-89.51	211.61
Dividend Per Share, 1 Yr. Growth %	130.56	-57.83	0	-42.86	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.46	35	4.92	-4.23	-3.74
Gross Profit, 2 Yr. CAGR %	13.44	-51.48	-44.13	8.07	-43.45
EBITDA, 2 Yr. CAGR %	13.54	-60.54	-41.4	48.38	-40.28
EBITA, 2 Yr. CAGR %	16.3	21.84	-67.28	0.64	111.2
EBIT, 2 Yr. CAGR %	17.86	46.17	-51.63	7.61	61.99
Earnings From Cont. Operations, 2 Yr. CAGR %	28.86	-60.17	-83.34	710.06	695.52
Net Income, 2 Yr. CAGR %	37.19	-37.66	-80.63	426.98	538.03
Normalized Net Income, 2 Yr. CAGR %	16.4	-6.23	-47.48	98.38	32.17
Diluted EPS Before Extra, 2 Yr. CAGR %	28.35	-37.57	-82.45	374.46	535.91
Accounts Receivable, 2 Yr. CAGR %	15.09	22.55	9.15	0.05	-11.29
Inventory, 2 Yr. CAGR %	28.95	27.94	0.16	5.16	1.91
Net Property, Plant and Equip., 2 Yr. CAGR %	0.25	21.97	37.1	22.04	0.87
Total Assets, 2 Yr. CAGR %	6.82	17.54	21.03	13.58	-3.59
Tangible Book Value, 2 Yr. CAGR %	6.64	7.84	-4.84	-8.65	-8.26
Common Equity, 2 Yr. CAGR %	4.47	6.04	3.9	-0.32	-10.02
Cash From Operations, 2 Yr. CAGR %	7.84	-64.26	-27.11	203.48	-21.31
Capital Expenditures, 2 Yr. CAGR %	-6.9	79.76	116.96	-7.09	-33.26
Levered Free Cash Flow, 2 Yr. CAGR %	45.58	162.86	206.93	-58.61	-37.16
Unlevered Free Cash Flow, 2 Yr. CAGR %	30.4	142.85	174.59	-69.12	-41.67
Dividend Per Share, 2 Yr. CAGR %	11.3	-1.4	-35.06	-24.41	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.08	13.78	17.73	4.08	-6.03
Gross Profit, 3 Yr. CAGR %	-3.12	-47.98	-12.42	-49.64	-3
EBITDA, 3 Yr. CAGR %	-3.45	-53.48	-11.86	-44.39	16.17
EBITA, 3 Yr. CAGR %	-7.14	-17.94	-27	-25.49	5.35
EBIT, 3 Yr. CAGR %	-7.59	-11.63	0.21	-16.83	7.31
Earnings From Cont. Operations, 3 Yr. CAGR %	-3.77	-68.12	-39.29	8.9	346.92
Net Income, 3 Yr. CAGR %	-5.19	-55.83	-31.9	8.65	220.99
Normalized Net Income, 3 Yr. CAGR %	-5.18	-44.48	23.95	-19.35	53.47
Diluted EPS Before Extra, 3 Yr. CAGR %	-4.34	-57.71	-36.23	1.4	199.65
Accounts Receivable, 3 Yr. CAGR %	8.75	13.26	17.72	3.16	-5.09
Inventory, 3 Yr. CAGR %	16.26	14.91	21.63	0.3	4.52
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.88	12.58	25.35	28.35	10.45
Total Assets, 3 Yr. CAGR %	3.21	10.15	19.97	14.77	5.12
Tangible Book Value, 3 Yr. CAGR %	5.61	4.84	1.27	-5.41	-9.09
Common Equity, 3 Yr. CAGR %	4.21	3.04	6.56	-0.11	-4.49
Cash From Operations, 3 Yr. CAGR %	2.48	-49.21	-15.55	1.24	42.92
Capital Expenditures, 3 Yr. CAGR %	-25.18	42.7	65.54	42.51	-14.49
Levered Free Cash Flow, 3 Yr. CAGR %	-17.41	175.53	87.53	19.13	-27.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	-10.82	141.59	75.03	-7.53	-32.37
Dividend Per Share, 3 Yr. CAGR %	-7.54	-19.46	-0.93	-37.77	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.5	7.01	4.41	6.2	8.62
Gross Profit, 5 Yr. CAGR %	-5.49	-41.06	-22.27	-30.31	-26.47
EBITDA, 5 Yr. CAGR %	-5.69	-44.83	-20.93	-26.01	-24.57
EBITA, 5 Yr. CAGR %	-9.07	-26.12	-38.82	-10.96	11.66
EBIT, 5 Yr. CAGR %	-9.61	-23.59	-28.67	-4.39	21.43
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.95	-58.59	-52.36	16.28	69.92
Net Income, 5 Yr. CAGR %	-6.02	-51.28	-49.86	19.06	66.65
Normalized Net Income, 5 Yr. CAGR %	-6.7	-40.62	-25.26	-6.76	27.17
Diluted EPS Before Extra, 5 Yr. CAGR %	-6.35	-51.28	-51.54	11.22	60
Accounts Receivable, 5 Yr. CAGR %	5.11	5.46	8.91	7.78	5.12
Inventory, 5 Yr. CAGR %	13.59	10.66	9.53	10.91	13.32
Net Property, Plant and Equip., 5 Yr. CAGR %	7.13	10.59	12.86	16.27	14.92
Total Assets, 5 Yr. CAGR %	7.59	6.5	9.99	11.51	9.93
Tangible Book Value, 5 Yr. CAGR %	11.51	6.23	1.28	-0.78	-2.66
Common Equity, 5 Yr. CAGR %	9.01	4.68	4.07	1.68	-0.41
Cash From Operations, 5 Yr. CAGR %	-11.26	-44.32	-10.58	3.83	-17.9
Capital Expenditures, 5 Yr. CAGR %	-13.61	5.12	14.54	20.19	15.11
Levered Free Cash Flow, 5 Yr. CAGR %	-2.88	31.03	39.63	29.08	21.1
Unlevered Free Cash Flow, 5 Yr. CAGR %	-2.28	28.37	39.84	6.1	12.78
Dividend Per Share, 5 Yr. CAGR %	-	-	-19.73	-21.48	-